(Q47397627)

15 January 2018

title

Clinical assessment of low molecular weight heparin effects in peripheral vascular disease (English)

1 reference

15 January 2018

1 reference

A Calabrò

1

1 reference

15 January 2018

F Piarulli

2

1 reference

15 January 2018

D Milan

3

1 reference

15 January 2018

A Rossi

4

1 reference

15 January 2018

G Coscetti

5

1 reference

15 January 2018

G Crepaldi

6

1 reference

15 January 2018

publication date

1 March 1993

1 reference

15 January 2018

published in

Angiology

1 reference

15 January 2018

volume

44

1 reference

15 January 2018

issue

3

1 reference

15 January 2018

page(s)

188-195

1 reference

15 January 2018

Efficacy of low-molecular-weight heparin in the management of intermittent claudication

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000331979304400304

The use of low molecular weight heparins for postsurgical deep vein thrombosis prevention in orthopaedic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979304400304

Effectiveness of thrombosis prevention with a low molecular weight heparin preparation in gynaecological patients undergoing surgery: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979304400304

Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979304400304

Effects of unfractionated heparin, dermatan sulfate and low molecular weight heparin on vessel wall permeability in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979304400304

Comparative human pharmacology of low molecular weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331979304400304

10.1177/000331979304400304

21 January 2018

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018